Mesothelioma and Asbestos

Competitive Technologies, Inc. has announced that the University of Miami Pain Management Center will now be using its pain therapy health examination device for their patients. The device provides non-invasive pain therapy without any of the harmful side effects of narcotic painkillers. The device has been approved by both the European Union as well as the U.S. Food as well as Drug Administration (FDA) to provide rapid treatment of intense cancer pain as well as neuropathic pain, including pain that is resistant to treatment by morphine as well as other medications. The pain therapy health examination device has successfully treated dozens of patients in the United States as well as thousands of patients in Europe, a large innovation in palliative care around the world.

For the filled story, go to Market Watch.